Hongyu Y. Chu

Changchun, 130033, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Liver microenvironment-driven immunosuppressive niche in colorectal cancer liver metastasis and its therapeutic remodeling.

Liver microenvironment-driven immunosuppressive niche in colorectal cancer liver metastasis and its therapeutic remodeling.

Journal: Frontiers in immunology

Published: June 11, 2026

JAK inhibition in PD-1 immunotherapy and tumor microenvironment.

JAK inhibition in PD-1 immunotherapy and tumor microenvironment.

Journal: Frontiers in immunology

Published: January 19, 2026

A Hydrogen-Releasing Nanozyme Engineers a Mitochondrial ROS Amplifier for Self-Sustaining Catalytic Immunotherapy.

A Hydrogen-Releasing Nanozyme Engineers a Mitochondrial ROS Amplifier for Self-Sustaining Catalytic Immunotherapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 16, 2025

Enhancing cancer immunotherapy through polymer-based antibody conjugation technologies.

Enhancing cancer immunotherapy through polymer-based antibody conjugation technologies.

Journal: Cancer biology & medicine

Published: November 26, 2025

Antibody-drug conjugates as immuno-oncology agents in colorectal cancer: targets, payloads, and therapeutic synergies.

Antibody-drug conjugates as immuno-oncology agents in colorectal cancer: targets, payloads, and therapeutic synergies.

Journal: Frontiers in immunology

Published: August 03, 2025

Hydrogen enhanced photothermal therapy for redox-regulated tumor apoptosis and immune reprogramming.

Hydrogen enhanced photothermal therapy for redox-regulated tumor apoptosis and immune reprogramming.

Journal: Acta biomaterialia

Published: June 10, 2025

Hyaluronic Acid Hydrogel Implants for Sustained Release of Oxaliplatin and Resiquimod to Prevent Hepatocellular Carcinoma Recurrence Post-Radiofrequency Ablation.

Hyaluronic Acid Hydrogel Implants for Sustained Release of Oxaliplatin and Resiquimod to Prevent Hepatocellular Carcinoma Recurrence Post-Radiofrequency Ablation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 23, 2025

Hypoxia-Activated Imidazoquinoline Prodrug Nanoparticles Potentiate Radiofrequency Ablation-Mediated Antitumor Immunity Against Hepatocellular Carcinoma.

Hypoxia-Activated Imidazoquinoline Prodrug Nanoparticles Potentiate Radiofrequency Ablation-Mediated Antitumor Immunity Against Hepatocellular Carcinoma.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: May 14, 2025

The Role of PLIN3 in Prognosis and Tumor-Associated Macrophage Infiltration: A Pan-Cancer Analysis.

The Role of PLIN3 in Prognosis and Tumor-Associated Macrophage Infiltration: A Pan-Cancer Analysis.

Journal: Journal of inflammation research

Published: November 28, 2024

Targeting T cell exhaustion: emerging strategies in non-small cell lung cancer.

Targeting T cell exhaustion: emerging strategies in non-small cell lung cancer.

Journal: Frontiers in immunology

Published: October 07, 2024

Targeted delivery and controlled release of polymeric nanomedicines for tumor therapy.

Targeted delivery and controlled release of polymeric nanomedicines for tumor therapy.

Journal: Fundamental research

Published: September 29, 2024

Interplay of disulfidptosis and the tumor microenvironment across cancers: implications for prognosis and therapeutic responses.

Interplay of disulfidptosis and the tumor microenvironment across cancers: implications for prognosis and therapeutic responses.

Journal: BMC cancer

Published: September 10, 2024

Showing 1-12 of 25

Last Updated: 09/26/2026